BIT
AXSM icon

BlackRock Institutional Trust’s Axsome Therapeutics AXSM Stock Holding History

BlackRock Institutional Trust’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$464K Buy
68,791
+12,687
+23% +$89.1K ﹤0.01% 3475
2016
Q3 		$442K Buy
56,104
+561
+1% +$4.25K ﹤0.01% 3510
2016
Q2 		$419K Buy
+55,543
New +$512K ﹤0.01% 3533

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Institutional Trust's AXSM Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Axsome Therapeutics (AXSM) stake by 23% in Q4 2016, buying an estimated $89.1K and bringing the position to 68,791 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #3475.

BlackRock Institutional Trust first reported a position in AXSM in Q2 2016 and has held it in 3 quarters since. 41 funds tracked by Wall St. Rank hold AXSM as of Q4 2016.

  • BlackRock Institutional Trust held 68,791 shares of Axsome Therapeutics worth $464K as of Q4 2016.
  • BlackRock Institutional Trust bought 12,687 Axsome Therapeutics shares in Q4 2016, an estimated $89.1K.
  • Axsome Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3475 holding.
  • BlackRock Institutional Trust first reported a position in Axsome Therapeutics in Q2 2016 and has held it in 3 quarters since.
  • 41 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.